Pantheon Investment Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$1.47M Sell
6,565
-840
-11% -$177K 1.16% 30
2021
Q3
$1.57M Buy
7,405
+458
+7% +$105K 1.35% 28
2021
Q2
$1.69M Buy
6,947
+1,443
+26% +$355K 1.42% 26
2021
Q1
$1.37M Sell
5,504
-804
-13% -$192K 1.31% 29
2020
Q4
$1.45M Buy
6,308
+1,492
+31% +$344K 1.58% 20
2020
Q3
$1.22M Sell
4,816
-236
-5% -$58.5K 1.46% 27
2020
Q2
$1.19M Sell
5,052
-279
-5% -$63.7K 1.5% 25
2020
Q1
$1.07M Sell
5,331
-417
-7% -$91.1K 1.61% 24
2019
Q4
$1.38M Buy
+5,748
New +$1.27M 1.3% 26

Other funds holding AMGN

Pantheon Investment Group's AMGN Position: Q4 2021 in Review

Pantheon Investment Group reduced its Amgen (AMGN) stake by 11% in Q4 2021, selling an estimated $177K and leaving 6,565 shares worth $1.47M. The position accounts for 1.16% of the portfolio, ranked #30.

Pantheon Investment Group first reported a position in AMGN in Q4 2019 and has held it in 9 quarters since. The position peaked at $1.69M in Q2 2021. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • Pantheon Investment Group held 6,565 shares of Amgen worth $1.47M as of Q4 2021.
  • Pantheon Investment Group sold 840 Amgen shares in Q4 2021, an estimated $177K.
  • Amgen made up 1.16% of Pantheon Investment Group's portfolio in Q4 2021, its #30 holding.
  • Pantheon Investment Group first reported a position in Amgen in Q4 2019 and has held it in 9 quarters since.
  • Pantheon Investment Group's Amgen position peaked at $1.69M in Q2 2021.
  • 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Pantheon Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.